```html

Keloidal Hyperpigmentation: A Comprehensive Guide

What is Keloidal Hyperpigmentation?

Keloidal hyperpigmentation describes a darkened, often thickened area of skin that results from an over‑production of melanin and collagen after an injury or inflammatory event. The term combines two phenomena:

• Keloid: a firm, raised scar that extends beyond the original wound margin.
• Hyperpigmentation: an excess of pigment (melanin) that makes the skin appear brown, black, or reddish.

When a keloid forms, the surrounding skin can become hyper‑pigmented, creating a patch that is both raised and darker than the surrounding tissue. This condition is most common among people with darker skin types (Fitzpatrick skin types III–VI) but can affect anyone who experiences abnormal scar formation.

Although keloidal hyperpigmentation is usually benign, it can cause cosmetic concern, itching, tenderness, and, in rare cases, functional limitation when it occurs near joints.

Common Causes

Several skin injuries or disorders can trigger the cascade that leads to keloid formation and subsequent hyperpigmentation. The most frequent culprits include:

• Acne vulgaris: Deep inflammatory lesions (cysts, nodules) are classic precursors to keloid scarring.
• Surgical incisions: Especially when tension on the wound edges is high or suturing technique is suboptimal.
• Trauma: Cuts, abrasions, piercings, and burns can all stimulate abnormal collagen deposition.
• Vaccination sites: Intramuscular injections in the deltoid region may leave keloidal scars in susceptible individuals.
• Ear piercing: The cartilage of the ear is a frequent site of keloid development.
• Dermatologic procedures: Laser resurfacing, cryotherapy, and chemical peels can paradoxically lead to keloids if healing is excessive.
• Inflammatory skin diseases: Conditions such as hidradenitis suppurativa, psoriasis, or lichen planus can produce chronic inflammation that predisposes to keloidal scarring.
• Genetic predisposition: A family history of keloids increases risk dramatically; inheritance is often autosomal‑dominant with variable expressivity.
• Hormonal influences: Pregnancy and puberty are periods of heightened melanin activity, which can intensify hyperpigmentation around a developing keloid.
• Infections: Post‑streptococcal infections or impetigo that cause deep dermal inflammation may result in pigmented keloids.

Associated Symptoms

While the primary sign is a dark, raised scar, patients often experience additional symptoms that help clinicians differentiate keloidal hyperpigmentation from other skin changes:

• Itching (pruritus): Common and can be severe enough to disrupt sleep.
• Pain or tenderness: Usually mild but can become pronounced if the keloid is under tension.
• Altered sensation: Numbness or paresthesia when nerves are trapped within the scar tissue.
• Redness (erythema): Especially during the active growth phase.
• Increased size: Keloids may continue to grow for months after the inciting injury.
• Secondary infection: If the overlying skin breaks, a bacterial infection can develop.
• Functional limitation: When keloids form across joints (e.g., over the knuckles or shoulder), range of motion may be reduced.

When to See a Doctor

Most keloidal hyperpigmentation can be managed with outpatient dermatology care, but certain signs warrant prompt medical evaluation:

• Rapid increase in size over weeks.
• Severe pain, throbbing, or a sensation of “tightness” that interferes with daily activities.
• Signs of infection – warmth, pus, foul odor, or fever.
• Sudden change in color to a dark purple or black, suggesting hemorrhage within the scar.
• Any doubt that the lesion could be a malignant melanoma or other skin cancer.
• Functional impairment, such as difficulty moving a joint.

If any of the above occur, schedule an appointment with a dermatologist or primary‑care provider within 1–2 days.

Diagnosis

Diagnosing keloidal hyperpigmentation is primarily clinical, but several tools may be employed to confirm the diagnosis and rule out mimickers.

History and Physical Examination

• Detailed wound‑history (type of injury, timing, healing course).
• Family history of keloids or hyperpigmentation disorders.
• Assessment of lesion size, borders, color, texture, and presence of surrounding erythema.

Dermoscopy

A handheld dermatoscope can reveal characteristic patterns—smooth, homogenous pigmentation with subtle vascular structures—helpful in distinguishing keloids from pigmented nevi or melanoma.

Skin Biopsy

Reserved for atypical lesions. Histology typically shows thick, hyalinized collagen bundles extending beyond the reticular dermis and an increased number of melanocytes in the basal layer.

Imaging (optional)

• Ultrasound can assess scar depth and vascularity.
• MRI is rarely needed but may be used for large keloids near joints to evaluate tissue involvement.

Treatment Options

Management aims to flatten the scar, reduce pigmentation, relieve symptoms, and prevent recurrence. A multimodal approach—combining medical, procedural, and home‑care measures—yields the best outcomes.

Topical Therapies

• Hydroquinone 4% or 2% (prescription): Inhibits tyrosinase, decreasing melanin production. Use for 4–8 weeks with sunscreen.
• Azelaic acid 15‑20% cream: Anti‑inflammatory and depigmenting; safe for sensitive skin.
• Silicone gel sheets or ointments: Provide occlusion, reduce tension, and can modestly lighten pigment over 3–6 months.
• Topical retinoids (tretinoin 0.025%–0.05%): Promote epidermal turnover and can fade discoloration.

Intralesional Injections

• Corticosteroids (triamcinolone acetonide 10‑40 mg/mL): Reduce collagen synthesis and inflammation; typically administered every 4‑6 weeks for 3–6 sessions.
• 5‑Fluorouracil (5‑FU): Often combined with steroids for refractory keloids; injects directly into the scar.
• Verapamil (calcium channel blocker): Shows promise in softening keloid tissue.

Procedural Interventions

• Laser therapy:
  • Pulsed‑Dye Laser (PDL) – targets vascular component, reduces redness.
  • Fractional CO₂ or Er:YAG lasers – vaporize scar tissue and stimulate remodeling; also improve pigmentation.
• Cryotherapy: Freezes keloid tissue, leading to necrosis and flattening; best for smaller lesions.
• Radiofrequency & Microneedling: Induce collagen remodeling and increase penetration of topical agents.
• Surgical excision: Removes the bulk of the scar but carries a high recurrence risk if not combined with adjuvant therapy (e.g., post‑op steroids or radiation).
• Radiation therapy: Low‑dose external beam after excision; reduces recurrence but reserved for stubborn keloids due to long‑term risk.

Systemic Options (Rare)

For extensive or multiple keloids, oral agents such as cromolyn sodium or antihistamines have been studied, but evidence is limited. Participation in a clinical trial may be considered.

Home Care & Adjuncts

• Gentle massage with a silicone‑based ointment twice daily to increase pliability.
• Sun protection – broad‑spectrum SPF 30+ applied every 2 hours when outdoors; UV exposure worsens hyperpigmentation.
• Regular moisturization to prevent dryness and itching.

Prevention Tips

Preventing keloidal hyperpigmentation starts with minimizing the initial scar and controlling pigment response.

• Optimize wound care: Keep wounds clean, moist, and covered; avoid excessive tension.
• Early intervention: If a scar appears raised within a month, consult a dermatologist for possible intralesional steroids.
• Use silicone gel sheets prophylactically on incisions in high‑risk individuals (dark skin, family history).
• Avoid unnecessary skin trauma: Limit repeated piercings or aggressive scratching of acne lesions.
• Sunshield all healing skin: UV radiation stimulates melanocytes, so apply sunscreen even on closed wounds.
• Consider prophylactic steroid injections after surgeries known to cause keloids (e.g., ear cartilage surgery).
• Educate patients: Explain that early signs of keloid formation (elevated, pinkish edges) merit prompt treatment.

Emergency Warning Signs

Key Take‑aways

Keloidal hyperpigmentation is a common, distressing sequela of abnormal scar formation, especially in individuals with darker skin tones. While it is primarily a cosmetic issue, it can cause itching, pain, and functional impairment. Early recognition, layered treatment—including topical depigmenting agents, intralesional steroids, and laser therapy—and diligent sun protection are the cornerstones of successful management. People at risk should practice meticulous wound care and seek prompt dermatologic advice if a scar begins to raise or darken.

References

• Mayo Clinic. Keloid scars: Causes, treatment, and prevention. https://www.mayoclinic.org
• American Academy of Dermatology. Hyperpigmentation. https://www.aad.org
• National Institutes of Health, National Library of Medicine. Keloid scar management: A systematic review. PMID: 31145720.
• Cleveland Clinic. How to treat scar hyperpigmentation. https://my.clevelandclinic.org
• World Health Organization. Dermatology: Guidance on skin of colour. 2022.
• Dermatologic Surgery. Combination therapy for refractory keloids. 2021;47(8):1120‑1128.

```